The purpose of this activity is to educate pharmacists on the efficacy, toxicity, and place in therapy for the new lung cancer drugs. The talk will cover the pivotal study data for new agents and discuss how they fit in the current guidelines as well as go over toxicity prevention and treatment.
- Knowledge Based
American Health Resources is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
Requirements for CE Credit
- Complete the pre-test
- Review the content of this activity
- Successfully complete the post-test with a score of 80% or higher
- Complete the activity evaluation
The reviewer is Steven L. D'Amato, RPh, BSPharm; Executive Director, New England Cancer Specialists; President of the Association of Community Cancer Centers; Clinical Associate Professor, Tufts University School of Medicine
- Identify the appropriate place in therapy for new targeted agents and how they compare to the standard treatment.
- Describe common and unique toxicities associated with targeted therapies.
- Recommend appropriate toxicity prevention and treatment measures for new targeted therapies to optimize outcomes.
Val R. Adams, PharmD, FCCP, BCOP
Brief Bio : Dr. Adams is an Associate Professor in the department of Pharmacy Practice and Science in the College of Pharmacy at the University of Kentucky. He is on the graduate faculty and is a member of the Markey Cancer Center where he has a clinical practice site. As the director of the hematology / oncology residency program, he has trained thirty one residents and maintains an active research lab. He received his B.S. in pharmacy from the University of Utah and received his doctor of pharmacy from the University of Texas at Austin jointly with the University of Texas Health Science Center at San Antonio. He completed a residency in hematology / oncology at the Audie L. Murphy Memorial V.A. Hospital in San Antonio, Texas. He then completed a two-year fellowship in immunology and transplantation at the University of Florida. Following the completion of the fellowship he joined the University of Kentucky faculty in 1996.